Development Level

Tbio 56 | 11,178
Tdark 11 | 6,569
Tchem 7 | 1,885
Tclin 2 | 612

IMPC Phenotype

preweaning lethality, complete... 10 | 979
embryonic lethality prior to o... 4 | 239
embryonic lethality prior to t... 3 | 278
abnormal behavior 2 | 298
abnormal bone mineralization 1 | 38
abnormal lens morphology 1 | 81
abnormal maxilla morphology 1 | 17
abnormal posture 1 | 2
abnormal retina morphology 1 | 71
abnormal retinal blood vessel ... 1 | 26
abnormal retinal vasculature m... 1 | 27
abnormal tooth morphology 1 | 24
cardiovascular system phenotyp... 1 | 36
cataract 1 | 92
decreased KLRG1+ CD4 alpha bet... 1 | 5
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating LDL chol... 1 | 38
decreased circulating sodium l... 1 | 22
decreased hemoglobin content 1 | 68
decreased lean body mass 1 | 135
decreased lumbar vertebrae num... 1 | 2
decreased sacral vertebrae num... 1 | 1
hemorrhage 1 | 23
hypoactivity 1 | 132
increased anti-nuclear antigen... 1 | 19
increased body temperature 1 | 9
increased circulating HDL chol... 1 | 80
increased circulating alkaline... 1 | 122
increased circulating calcium ... 1 | 34
increased circulating choleste... 1 | 66
increased circulating creatini... 1 | 38
increased circulating free fat... 1 | 20
increased circulating potassiu... 1 | 29
increased circulating triglyce... 1 | 42
increased hemoglobin content 1 | 45
increased lumbar vertebrae num... 1 | 1
increased sacral vertebrae num... 1 | 1
increased total body fat amoun... 1 | 134
thrombocytopenia 1 | 56
trunk curl 1 | 16

Disease

ovarian cancer 39 | 8,297
Carcinoma 38 | 11,192
lung cancer 31 | 4,607
osteosarcoma 26 | 7,766
psoriasis 23 | 6,514
Cancer 18 | 2,388
glioblastoma 17 | 5,635
group 3 medulloblastoma 16 | 4,002
Breast cancer 15 | 3,469
lung adenocarcinoma 15 | 2,627
medulloblastoma, large-cell 14 | 6,086
Multiple myeloma 13 | 1,296
atypical teratoid / rhabdoid tumor 13 | 4,971
Cockayne syndrome 11 | 59
Photosensitive trichothiodystrophy 11 | 30
invasive ductal carcinoma 11 | 2,867
non-small cell lung cancer 11 | 2,799
ductal carcinoma in situ 10 | 1,686
ependymoma 10 | 4,559
primitive neuroectodermal tumor 10 | 2,957
breast carcinoma 9 | 1,589
group 4 medulloblastoma 9 | 1,806
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,902
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,204
malignant mesothelioma 9 | 3,135
Intellectual disability 8 | 998
Schizophrenia 8 | 1,136
pancreatic ductal adenocarcinoma liver metastasis 8 | 1,911
Kidney cancer 7 | 2,548
colon cancer 7 | 1,428
pancreatic cancer 7 | 2,322
pediatric high grade glioma 7 | 1,035
subependymal giant cell astrocytoma 7 | 2,230
Cleft Palate 6 | 265
Endometriosis 6 | 521
Pick disease 6 | 1,856
Xeroderma pigmentosum 6 | 42
Xeroderma pigmentosum group B 6 | 20
astrocytoma 6 | 1,113
diabetes mellitus 6 | 1,683
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,872
spina bifida 6 | 1,053
Astrocytoma, Pilocytic 5 | 3,006
Hypoplastic mandible condyle 5 | 273
Mandibular hypoplasia 5 | 273
Micrognathism 5 | 273
Strabismus 5 | 265
Waldenstrons macroglobulinemia 5 | 742
Xeroderma pigmentosum group D 5 | 32
acute myeloid leukemia 5 | 760
adult high grade glioma 5 | 3,701
cystic fibrosis 5 | 1,629
nasopharyngeal carcinoma 5 | 1,024
Autosomal recessive predisposition 4 | 1,407
Broad flat nasal bridge 4 | 232
Carcinoma, Squamous Cell 4 | 107
Cataract 4 | 290
Cerebellar Ataxia 4 | 302
Dull intelligence 4 | 634
Low Vision 4 | 167
Low intelligence 4 | 634
Mental Retardation 4 | 634
Mental deficiency 4 | 634
Nasal bridge wide 4 | 232
Poor school performance 4 | 634
Rheumatoid arthritis 4 | 1,156
Small head 4 | 366
Squamous cell carcinoma 4 | 125
Treacher Collins syndrome 4 | 27
Visual Impairment 4 | 167
Xeroderma pigmentosum group G 4 | 16
acute quadriplegic myopathy 4 | 1,133
cutaneous lupus erythematosus 4 | 1,016
dermatomyositis 4 | 941
gastric cancer 4 | 445
non-small cell lung carcinoma 4 | 302
oligodendroglioma 4 | 2,768
pancreatic carcinoma 4 | 555
pituitary cancer 4 | 1,915
posterior fossa group A ependymoma 4 | 456
Atrophy of cerebellum 3 | 101
Cerebellar degeneration 3 | 101
Congenital small ears 3 | 46
Epilepsy 3 | 775
Failure to gain weight 3 | 359
Gliosis 3 | 56
Infratentorial atrophy 3 | 101
Melanoma 3 | 689
Mental Depression 3 | 325
Mood Disorders 3 | 181
Muscle Spasticity 3 | 192
Pediatric failure to thrive 3 | 359
Prostatic Neoplasms 3 | 472
Seizures 3 | 584
Stomach Neoplasms 3 | 287
astrocytic glioma 3 | 2,530
hepatocellular carcinoma 3 | 536
juvenile dermatomyositis 3 | 1,147
sonic hedgehog group medulloblastoma 3 | 459
tuberculosis 3 | 1,963

Tissue

Endocrine System 74 | 18,159
Blood and immune system 73 | 16,909
Digestive Tract 73 | 17,369
Female tissues 73 | 17,400
Skin and soft tissues 73 | 17,230
Cardiovascular System 72 | 15,192
Liver and Pancreas 72 | 16,750
Male tissues 72 | 17,142
Nervous System 72 | 16,725
Respiratory system 72 | 16,393
Urinary Tract 72 | 16,678

Target Family

Non-IDG 38 | 12,091
Enzyme 21 | 4,145
Transcription Factor 8 | 1,400
Epigenetic 7 | 242
Kinase 2 | 634

Reactome Pathway

RNA Polymerase I Promoter Clea... 76 | 76
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
TATA-box-binding protein TBP Tbio Non-IDG -3.27246 1844.4 387
Histone acetyltransferase KAT2A KAT2A Tbio Epigenetic -2.46487 271.9 262
Histone H2B type 1-D HIST1H2BD Tbio Non-IDG -1.07400 11.6 71
Metastasis-associated protein MTA3 MTA3 Tbio Transcription Factor -1.36174 24.5 204
Histone H2A.J H2AFJ Tdark Non-IDG -0.00172 0.83 99
Metastasis-associated protein MTA2 MTA2 Tbio Transcription Factor -1.59201 32.3 283
DNA-directed RNA polymerases I and III subunit RPAC1 POLR1C Tbio Enzyme -1.58188 37.0 209
Histone-lysine N-methyltransferase EHMT2 EHMT2 Tchem Epigenetic -2.49970 327.4 277
General transcription factor IIH subunit 1 GTF2H1 Tbio Non-IDG -1.65323 46.0 231
DNA-directed RNA polymerase I subunit RPA43 TWISTNB Tdark Enzyme -0.05799 1.13 69